Castro, of University of Kansas discusses interim phase 1b data showing rapid, durable suppression in patients with mild to moderate asthma.
Mario Castro, MD, MPH
Advertisement
Articles by Mario Castro, MD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Alpha-Gal Syndrome: Closing an Underrecognized Allergy Diagnostic Gap
2
GRI-0621 Improves FVC, Reduces Fibrotic Biomarkers in IPF
3
ORFAN-MAESTRIA: AI Predicts Cardioembolic Stroke, Atrial Fibrillation from CT Scans
4
Pelacarsen Misses Primary Endpoint in Lp(a)HORIZON Phase 3 Trial
5